Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230

Journal of Autoimmunity

Volumn 24, Issue 1, 2005, Pages 1-10

  Kiss, Mária ^a   Husz, Sándor ^a   Jánossy, Tamás ^b   Marczinovits, Ilona ^a   Molnár, János ^a   Korom, Irma ^a   Dobozy, Attila ^a,c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Bullous pemphigoid; Experimental mouse model; Protein BP230; Subepidermal blister formation

Indexed keywords

BULLOUS PEMPHIGOID ANTIGEN 1; EPITOPE; IMMUNOGLOBULIN G;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PURIFICATION; ANTIGENICITY; ARTICLE; BLISTER; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EPIDERMIS; ERYTHEMA; EXPERIMENTAL MODEL; FRICTION; GRANULOCYTE FUNCTION; HEMIDESMOSOME; IMMUNOHISTOLOGY; INJECTION; INTERMETHOD COMPARISON; NEWBORN; NONHUMAN; PATHOGENESIS; PEMPHIGOID; PRIORITY JOURNAL; RABBIT; SEQUENCE HOMOLOGY; SKIN DEFECT; STATISTICAL SIGNIFICANCE; SYMPTOM;

EID: 13944253591     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2004.09.007     Document Type: Article

References (39)

1. J.R. Stanley Bullous pemphigoid I.M. Freedberg Fitzpatrick's dermatology in general medicine 1999 McGraw-Hill New York, New York, USA 666 671
2. R.S. Labib, G.J. Anhalt, H.P. Patel, D.F. Mutasin, and L.A. Diaz Molecular heterogenicity of the bullous pemphigoid antigens as detected by immunoblotting J Immunol 136 1986 1231 1235
3. K.B. Yancey, and C.A. Egan Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations JAMA 284 2000 350 356
4. D. Zillikens, P.A. Rose, S.D. Balding, Z. Liu, M. Olague-Marchan, and L.A. Diaz Tight clustering of extracellular BP 180 epitopes recognized by bullous pemphigoid autoantibodies J Invest Dermatol 109 1997 573 579
5. E. Schmidt, S. Reimer, N. Kruse, S. Jainta, E.-B. Bröcker, and M.P. Marinkovich Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes J Invest Dermatol 115 2000 842 848 10.1046/J.1523-1747.2000.00141.x
6. C. Sitaru, E. Schmidt, S. Petermann, L.S. Munteanu, E.-B. Bröcker, and D. Zillikens Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin J Invest Dermatol 118 2002 664 671 10.1046/J.1523-1747.2002.01720.x
7. E. Schmidt, K. Obe, E.-B. Bröcker, and D. Zillikens Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid Arch Dermatol 136 2000 174 178
8. Z. Liu, L.A. Diaz, J.L. Troy, A.F. Taylor, D.J. Emery, and J.A. Fairley A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180 J Clin Invest 92 1993 2480 2488
9. Z. Liu, G.J. Giudice, S.J. Swartz, J.A. Fairley, G.O. Till, and J.L. Troy The role of complement in experimental bullous pemphigoid J Clin Invest 95 1995 1539 1544
10. Z. Liu, G.J. Giudice, X. Zhou, S.J. Swartz, J.L. Troy, and J.A. Fairley A major role for neutrophils in experimental bullous pemphigoid J Clin Invest 100 1997 1256 1263
11. Z. Liu, S.D. Shapiro, X. Zhou, S.S. Twining, R.M. Senior, and G.J. Giudice A critical role for neutrophil elastase in experimental bullous pemphigod J Clin Invest 105 2000 113 123
12. S. Verraes, W. Hornebeck, M. Polette, L. Borradori, and P. Bernard Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid J Invest Dermatol 117 2001 1091 1096 10.1046/J.0022-202x2001.01521.x
13. Z. Liu Bullous pemphigoid: using animal models to study the immunopathology J Invest Dermatol Symp Proc 9 2004 41 46
14. K.J. Green, M.L.A. Virata, D.W. Elgart, J.R. Stanley, and D.A.D. Parry Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin: members of a new gene family involved in organization of intermediate filaments Int J Biol Macromol 14 1992 145 153
15. Y. Yang, J. Dowling, Q.-C. Yu, P. Kouklis, D.W. Cleveland, and E. Fuchs An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments Cell 86 1996 655 665
16. M. Gaucherand, J.F. Nicolas, G. Paranhos Baccala, J.P. Rouault, A. Réano, and J.P. Magaud Major antigenic epitopes of bullous pemphigoid 230 kDa antigen map within the C-terminal end of the protein. Evidence using a 55 kDa recombinant protein Br J Dermatol 132 1995 190 196
17. A. Ide, T. Hashimoto, M. Amagai, M. Tanaka, and T. Nishikawa Detection of autoantibodies against bullous pemphioid and pemphigus antigens by an enzyme-linked immunosorbent assay using the bacterial recombinant proteins Exp Dermatol 5 1995 112 116
18. M.J. Rico, N.J. Korman, J.R. Stanley, T. Tanaka, and R.P. Hall IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded by bullous pemphigoid antigen cDNA J Immunol 145 1990 3728 3733
19. M.J. Rico, T. Hashimoto, K. Watanabe, R.P. Hall, R.B. Clark, and T. Nishikawa Comparative epitope mapping of sera from United States (US) and Japanese patients with bullous pemphigoid (BP) to fusion proteins encoded by BPAG1 J Dermatol Sci 12 1996 238 245
20. M. Skaria, F. Jaunin, T. Hunziker, S. Riou, H. Schumann, and L. Bruckner-Tuderman IgG antibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230 J Invest Dermatol 114 2000 998 1004 10.1046/J.1523-1747.2000.00893.x
21. T. Hamada, Y. Nagata, M. Tomita, W. Salmhofer, and T. Hashimoto Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule Exp Dermatol 10 2001 256 263 10.1034/J.1600-0625.2001.100405.x
22. S. Husz, M. Kiss, K. Molnár, I. Marczinovits, J. Molnár, and G.K. Tóth Development of a system for detection of circulating antibodies against hemidesmosomal proteins in patients with bullous pemphigoid Arch Dermatol Res 292 2000 217 224
23. I. Marczinovits, Cs. Somogyi, A. Patthy, P. Németh, and J. Molnár An alternative purification protocol for producing hepatitis B virus × antigen on a preparative scale in Escherichia coli J Biotechnol 56 1997 81 88 10.1016/S0168-1656(97)00080-1
24. T. Hashimoto, M.M. Ogawa, A. Konohana, and T. Nishikawa Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources J Invest Dermatol 94 1990 327 331
25. M. Kiss, S. Husz, K. Molnár, and A. Dobozy Identification of different circulating autoantibodies in patients with bullous pemphigoid and pemphigus vulgaris by means of immunoblotting Acta Microbiol Immunol Hung 43 1996 115 123
26. J.R. Stanley, P. Hawley-Nelson, S.H. Yuspa, E.M. Shevach, and S.I. Katz Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia Cell 24 1981 897 903
27. S.M. Mueller, V. Klaus Kovtun, and J.R. Stanley A 230 kD basic protein is the major bullous pemphigoid antigen J Invest Dermatol 92 1989 33 38
28. N.J. Korman In situ-bound antibodies eluted from the skin of patients with bullous pemphigoid are preferentially directed against the 230-kD bullous pemphigoid antigen J Invest Dermatol 105 1995 824 830
29. L. Borradori Autoantibodies against BP230 and BP180 in bullous pemphigoid (BP): which is important? JEADV 16 Suppl. 1 2002 6(A)
30. I. Laczkó, E. Vass, G.K. Tóth, I. Marczinovits, M. Kiss, and S. Husz Conformational consequences of coupling bullous pemphigoid antigenic peptides to glutathione-S-transferase and their diagnostic significance J Pept Sci 6 2000 378 386
31. W.M. Sams Jr., and G.J. Gleich Failure to transfer bullous pemphigoid with serum from patients Proc Soc Exp Biol Med 136 1971 1027 1031
32. W.R. Gammon, and R.A. Briggaman Absence of specific histologic changes in guinea pig skin treated with bullous pemphigoid J Invest Dermatol 90 1988 495 500
33. R. Chen, G. Ning, M.-L. Zhao, M.G. Fleming, L.A. Diaz, and Z. Werb Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid J Clin Invest 108 2001 1151 1158
34. R. Chen, J.A. Fairley, M.-L. Zhao, G.J. Giudice, D. Zillikens, and L.A. Diaz Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation J Immunol 169 2002 3987 3992
35. R.P. Hall III, J.C. Murray, M.M. McCord, M. Joyce Rico, and R.D. Streilein Rabbits immunized with a peptide encoded for by the 230 kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid J Invest Dermatol 101 1993 9 14
36. T.D. Golan, A.E. Ghavari, and K.B. Elkon Penetration of autoantibodies into living epithelial cells J Invest Dermatol 100 1993 316 322
37. A. Ishiko, H. Shimizu, A. Kikuchi, T. Ebihara, T. Hashimoto, and T. Nishikawa Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin J Clin Invest 91 1993 1608 1615
38. D. Alarcon-Segovia, A. Ruiz-Argüelles, and L. Llorente Broken dogma: penetration of autoantibodies into living cells Immunol Today 17 1996 163 164
39. A. Ruiz-Arguelles, B. Perez-Romano, L. Llorente, D. Alarcon-Segovia, and J.M. Castellanos Penetration of anti-DNA antibodies into immature live cells J Autoimmun 11 1998 547 556 10.1006/jaut.1998.0216